Home

מנטה מאפיין הוא j bioorg med chem lett אוניברסיטה כניעה שכבה

Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors

Bioorganic & Medicinal Chemistry Letters | Vol 21, Issue 21, Pages 6207-6614 (1 November 2011) | ScienceDirect.com by Elsevier
Bioorganic & Medicinal Chemistry Letters | Vol 21, Issue 21, Pages 6207-6614 (1 November 2011) | ScienceDirect.com by Elsevier

Design, Synthesis, and Evaluation of Highly Potent FAK-Targeting PROTACs | ACS Medicinal Chemistry Letters
Design, Synthesis, and Evaluation of Highly Potent FAK-Targeting PROTACs | ACS Medicinal Chemistry Letters

Publications & Patents - The Trippier Lab
Publications & Patents - The Trippier Lab

Bioorganic & Medicinal Chemistry Letters | Vol 26, Issue 15, Pages 3381-3830 (1 August 2016) | ScienceDirect.com by Elsevier
Bioorganic & Medicinal Chemistry Letters | Vol 26, Issue 15, Pages 3381-3830 (1 August 2016) | ScienceDirect.com by Elsevier

Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry

名古屋大学大学院創薬科学研究科 天然物化学分野
名古屋大学大学院創薬科学研究科 天然物化学分野

PDF) Corrigendum to “Pyridine containing M1 positive allosteric modulators with reduced plasma protein binding” [Bioorg. Med. Chem. Lett. 20 (2010) 657] | Lei Ma - Academia.edu
PDF) Corrigendum to “Pyridine containing M1 positive allosteric modulators with reduced plasma protein binding” [Bioorg. Med. Chem. Lett. 20 (2010) 657] | Lei Ma - Academia.edu

Bioorganic & Medicinal Chemistry Letters | Vol 30, Issue 17, 1 September 2020 | ScienceDirect.com by Elsevier
Bioorganic & Medicinal Chemistry Letters | Vol 30, Issue 17, 1 September 2020 | ScienceDirect.com by Elsevier

Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry

成果及论文 - 南华大学王震课题组
成果及论文 - 南华大学王震课题组

Targeting IRAK4 for Degradation with PROTACs | ACS Medicinal Chemistry Letters
Targeting IRAK4 for Degradation with PROTACs | ACS Medicinal Chemistry Letters

PROTAC Technology: Opportunities and Challenges | ACS Medicinal Chemistry Letters
PROTAC Technology: Opportunities and Challenges | ACS Medicinal Chemistry Letters

PDF) Design, synthesis, and preliminary biological evaluation of novel ethyl 1-(2 '-hydroxy-3 '-aroxypropyl)-3-aryl-1H-pyrazole-5-carboxylate
PDF) Design, synthesis, and preliminary biological evaluation of novel ethyl 1-(2 '-hydroxy-3 '-aroxypropyl)-3-aryl-1H-pyrazole-5-carboxylate

Bioorganic
Bioorganic

PDF) Corrigendum to “Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides” [Bioorg. Med. Chem. Lett. 26 (2016) 5867–5870]
PDF) Corrigendum to “Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides” [Bioorg. Med. Chem. Lett. 26 (2016) 5867–5870]

Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry

Bioorganic & Medicinal Chemistry Letters | Vol 28, Issue 14, Pages 2343-2576 (1 August 2018) | ScienceDirect.com by Elsevier
Bioorganic & Medicinal Chemistry Letters | Vol 28, Issue 14, Pages 2343-2576 (1 August 2018) | ScienceDirect.com by Elsevier

PDF) 2-Alkyl/alkenyl substituted pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonists
PDF) 2-Alkyl/alkenyl substituted pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonists

Figure 3, Summary of second generation small molecule 3CLpro inhibitors, some containing reactive warhead groups and known to have a covalent mode of action - Probe Reports from the NIH Molecular Libraries
Figure 3, Summary of second generation small molecule 3CLpro inhibitors, some containing reactive warhead groups and known to have a covalent mode of action - Probe Reports from the NIH Molecular Libraries